At NASS 2018, Advanced Biomaterials and the Pull of Robots

article image

The backdrop for NASS was a chal┬Členged marketplace and excitement around robotics, which is seeing grow┬Čing acceptance, albeit off a small base. Debates continue over the abilities of new biomaterials versus biologics to address gaps in care.

Robotics once again took center stage on the NASS exhibitor floor, as two front runners, Medtronic plc and Globus Medical Inc. gear up to fight for dominance of this market, which is just emerging in spine.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: